Evidence map›Paper›PMID 34961231›Full record

ReviewPlants (Basel, Switzerland)2021

Engineering Considerations to Produce Bioactive Compounds from Plant Cell Suspension Culture in Bioreactors.

Elizabeth Alejandra Motolinía-Alcántara, Carlos Omar Castillo-Araiza, Mario Rodríguez-Monroy, Angélica Román-Guerrero, Francisco Cruz-Sosa

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. PlantInternational journal of molecular sciences · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Cascade Oxygen Control Enhances Growth ofPlants (Basel, Switzerland) · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Huperzine A Production and Acetylcholinesterase Inhibition byPharmaceuticals (Basel, Switzerland) · 2025
    Article
  15. Impact ofBiotech (Basel (Switzerland)) · 2025
    Article
  16. Model-based fed-batch cultivation ofFrontiers in bioengineering and biotechnology · 2025
    Article
  17. Article
  18. Phytochemical Profiles and Cytotoxic Activity ofPlants (Basel, Switzerland) · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elizabeth Alejandra Motolinía-AlcántaraDepartamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa, Av. Ferrocarril de San Rafael Atlixco 186, Ciudad de México 09310, Mexico.
Carlos Omar Castillo-AraizaDepartamento de Ingeniería de Procesos e Hidráulica, Universidad Autónoma Metropolitana-Iztapalapa, Av. Ferrocarril de San Rafael Atlixco 186, Ciudad de México 09310, Mexico.ORCID 0000-0001-8719-0473
Mario Rodríguez-MonroyCentro de Desarrollo de Productos Bióticos (CEPROBI), Departamento de Biotecnología, Instituto Politécnico Nacional (IPN), Yautepec 62731, Mexico.
Angélica Román-GuerreroDepartamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa, Av. Ferrocarril de San Rafael Atlixco 186, Ciudad de México 09310, Mexico.ORCID 0000-0002-9686-0106
Francisco Cruz-SosaDepartamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa, Av. Ferrocarril de San Rafael Atlixco 186, Ciudad de México 09310, Mexico.ORCID 0000-0002-7127-7264

Funding

Consejo Nacional de Ciencia y Tecnología 616138
6 · The paper itself

Abstract

The large-scale production of plant-derived secondary metabolites (PDSM) in bioreactors to meet the increasing demand for bioactive compounds for the treatment and prevention of degenerative diseases is nowadays considered an engineering challenge due to the large number of operational factors that need to be considered during their design and scale-up. The plant cell suspension culture (CSC) has presented numerous benefits over other technologies, such as the conventional whole-plant extraction, not only for avoiding the overexploitation of plant species, but also for achieving better yields and having excellent scaling-up attributes. The selection of the bioreactor configuration depends on intrinsic cell culture properties and engineering considerations related to the effect of operating conditions on thermodynamics, kinetics, and transport phenomena, which together are essential for accomplishing the large-scale production of PDSM. To this end, this review, firstly, provides a comprehensive appraisement of PDSM, essentially those with demonstrated importance and utilization in pharmaceutical industries. Then, special attention is given to PDSM obtained out of CSC. Finally, engineering aspects related to the bioreactor configuration for CSC stating the effect of the operating conditions on kinetics and transport phenomena and, hence, on the cell viability and production of PDSM are presented accordingly. The engineering analysis of the reviewed bioreactor configurations for CSC will pave the way for future research focused on their scaling up, to produce high value-added PDSM.

Indexed as

bioactive compoundsbioreactor engineeringcell suspension culture (CSC)medicinal plantplant-derived secondary metabolites (PDSM)

Identifiers

PMID34961231
PMCPMC8707313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.